Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Siemens healthcare diagnostics received customer feedback on the advia centaur systems insulin assay indicating a low but increased rate of calibration failures for the advia centaur systems insulin assay. a limited number of customers have experienced the calibration failures. this issue is not applicable to the advia centaur cp.